Literature DB >> 1622854

Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas.

P Casali1, U Pastorino, P Zucchinelli, L Devizzi, A Azzarelli, V Quagliuolo, P Bignami, A Santoro, G Bonadonna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1622854     DOI： 10.1093/annonc/3.suppl_2.s125

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

Review 1.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

2.  Extremely rare case of successful treatment of metastatic ovarian undifferentiated carcinoma with high-dose combination cytotoxic chemotherapy: A case report.

Authors:  Hong Beum Kim; Hee Jeong Lee; Ran Hong; Sang-Gon Park
Journal:  World J Clin Cases       Date:  2020-10-06       Impact factor: 1.337
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.